The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index; 12 of the 35 sources its claims cite were checked for support.
Endothelial destabilization by angiopoietin-2 via integrin β1 activation
Open accessAbstract
Angiopoietin-2 activates β1-integrin and promotes endothelial destabilization, including changes in VE-cadherin junctions and transendothelial tumour-cell migration.
Overview
CoChat Summary
TL;DR
Angiopoietin-2 (Ang2), but not Ang1, directly activates β1-integrin and promotes endothelial destabilization via Tie2-independent signaling. This mechanism involves Ang2 N-terminal domains, β1-integrin-dependent matrix adhesions and stress fibers, and is blocked by membrane-bound Tie2 ectodomain.
Key findings
- Ang2 activates β1-integrin in endothelial and non-endothelial cells; Ang1 does not. In CHO-cell fibronectin-binding assays, 150 nM (10 μg ml−1) Ang2 stimulated FN7–10 binding as well as ectopic talin head domain expression, whereas Ang1 had no effect even at higher concentrations.
- Tie2 silencing in human dermal blood microvascular endothelial cells (BECs) induced elongated morphology, loss of cortical actin, actin stress fibers, reduced VE-cadherin/β-catenin at cell–cell contacts, and increased active β1-integrin in central elongated adhesions. These changes were rescued by Ang2+Tie2 double silencing, β1-integrin silencing, PI3K inhibition, Rho kinase inhibition, or expression of membrane-bound murine Tie2 ectodomain (mTie2-ECD).
- Ang2 bound directly to the β1-integrin subunit in ELISA. The Ang2 N-terminal superclustering/coiled-coil domains promoted β1-integrin activation and stress fibers, whereas Ang1–Ang2 chimeras and angiopoietin FLD-Fc proteins did not activate β1-integrin.
- In VEC-tTA/Tet-OS-Ang2 transgenic mice, aortic endothelium showed more irregular VE-cadherin staining, central active β1-integrin adhesions, central actin fibers, and reduced junctional Tie2 compared with wild-type mice. Ang2-blocking antibodies inhibited transendothelial migration of LNM-35 cells, while Tie2-silenced endothelium was more permissive for LLC-GFP transmigration.
Methods
- Cell models: human dermal BECs, human pulmonary microvascular endothelial cells, HeLa, CHO, LLC, and LNM-35 cells; shRNA/siRNA silencing of Tie2, Ang2, Tie1, β1-integrin, αv, β3, and β5; angiopoietin stimulation with recombinant human Ang1/Ang2 (60 nM, 4 μg ml−1, 30 min for HeLa).
- Assays: immunofluorescence for actin, VE-cadherin, β-catenin, ZO-1, active β1-integrin, CD31, and Tie2; adhesion and fibronectin matrix remodeling assays; Transwell tumour-cell transmigration; FACS-based integrin activation assay using Alexa-647-conjugated fibronectin fragment FN7–10 normalized to total α5β1; ELISA for Ang2–β1-integrin binding.
- In vivo: VEC-tTA/Tet-OS-Ang2 mice with postnatal endothelial Ang2 induction; en face whole-mount staining of mouse aorta for VE-cadherin, CD31, active β1-integrin, F-actin, and Tie2. Statistics used Student’s t-test (two-tailed, unequal variance) and Dunnett’s test; P < 0.05 considered significant.
Limitations
- The paper states that its results “do not rule out additional interactions with β1-integrin, mediated via the C-terminal domains of Ang2 or Ang1.”
- For the Ang2 transgenic mouse phenotype, the paper states that “the mechanism remains to be fully elucidated.”
- Evident from the text: much of the mechanistic evidence comes from Tie2-silenced cultured endothelial cells and HeLa/CHO overexpression or recombinant systems; in vivo evidence is limited to aortic endothelium of Ang2 transgenic mice, without direct in vivo β1-integrin blockade.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
12 Valid · 0 Not valid · 21 Not checked · 74 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“During vascular development, Ang2 inhibition blocked VE-cadherin phosphorylation at tyrosine residue 685 and the concomitant formation of button-like junctions in initial lymphatic vessels20”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Abstract
What the sources say
- Supportedcites [20] Zheng, W et al. Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions. Genes Dev. 28, 1592–1603 (2014). source
The Results section reports that ANG2 blockade left little VE-cadherin phosphorylation at Y685 in embryonic initial lymphatics and that the junctions failed to transform from zippers to buttons at the same time. It also reports that ANG2 inhibition suppressed essentially all button formation. The claim describes these concurrent effects, not a causal link between them. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“We used the VEC-tTA/Tet-OS-Ang2 mouse line, which expresses mouse Ang2 under an inducible endothelial cell promoter19.”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Methods > Animal models
What the sources say
- Supportedcites [19] Holopainen, T. et al. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl Cancer Inst. 104, 461–475 (2012). source
The Methods (Mice) describe a responder construct containing the full-length mouse Ang2 coding sequence under a tetracycline-responsive promoter, bred with a VE-cadherin-tTA driver line. The Results (The Effect of Ang2 Overexpression on Metastasis of Human Lung Carcinoma Xenografts) state that this construct drives endothelial Ang2 expression when tetracycline is discontinued. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We found that antibodies blocking the Ang2–Tie2 interaction reduced tumour cell transendothelial migration, in line with previously published in vivo data19.”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Results and Discussion > Changes in the aortic endothelium of Ang2 transgenic mice
What the sources say
- Partly supportedcites [19] Holopainen, T. et al. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl Cancer Inst. 104, 461–475 (2012). sourceExperimental — accuracy not yet measured
The Discussion reports fewer early lung tumour-cell colonies after Ang2-blocking antibody treatment and suggests that blocking Ang2 may inhibit extravasation. It also states that extravasation was not imaged, so the paper provides consistent in vivo evidence rather than a direct finding of reduced transendothelial migration. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“To overcome the embryonic lethality due to endothelial Ang2 overexpression in double-transgenic embryos, Ang2 expression was repressed during the entire pregnancy.”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Methods > Animal models
What the sources say
- Supportedcites [19] Holopainen, T. et al. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis. J. Natl Cancer Inst. 104, 461–475 (2012). source
The Methods > Mice passage explicitly says that endothelial Ang2 overexpression caused embryonic lethality in double-transgenic embryos and that Ang2 expression was repressed throughout pregnancy to overcome it. No page number is provided in our copy. (LLM, conf=0.95)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“Of note, a 150 nM (10 μg ml−1) concentration of Ang2 stimulated FN7–10 binding to CHO cells equally well as the ectopic expression of the talin head domain, a prominent inside-out activator of β1-integrin44.”
§ Endothelial destabilization by angiopoietin-2 via integrin β1 activation > Results and Discussion > Ang2, but not Ang1, activates β1-integrin
What the sources say
- Not checked yetcites [44] Calderwood, D. A. et al. The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J. Biol. Chem. 274, 28071–28074 (1999). source
Checked before — its earlier verdict is held back until a new check runs.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
48 more claims
Create a free account to see all 107 claims and to verify the 3 references still open.
- Probably not a substantial claim. 10
- It may state two separate claims as one. 48
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, ANGPT2 was recently reported to activate α5β1-integrin, leading to endothelial monolayer destabilization (15).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We previously showed that, in addition to TIE2, ANGPT2 can signal via α5β1-integrin, leading to destabilization of EC monolayers where TIE2 levels are low (15).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“Recent studies have demonstrated that beyond the primary signaling mode through TIE2, ANGPTs can also signal via integrins to modulate vascular responses (13, 21–25).”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Because we previously found that the ANGPT2 N-terminus, but not that of ANGPT1, activated α5β1-integrin (22), and here we further show that the ANGPT1 N-terminus does not bind β1-integrin, these data suggest ANGPT2 may facilitate α5β1-integrin activation by interacting with the hybrid/PSI domain in a unique manner not mediated by ANGPT1.”
From Inactive β1-integrin acts as a junctional scaffold for angiopoietin/TIE2/FOXO1 signaling (2026) · cites this paper as [22]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“By contrast, β3-integrin (shβ3) silencing decreased VE-cadherin in BECs, in line with previous studies (9, 15), and shβ3 did not prevent the thrombin-induced loss of VE-cadherin (Fig. 2 C and D and SI Appendix, Fig. S3A).”
From Targeting β1-integrin inhibits vascular leakage in endotoxemia (2018) · cites this paper as [15]
Experimental — accuracy not yet measured
Citations
Cites
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Chiu, J.-J., & Chien, S. (2011) · Physiological Reviews · doi:10.1152/physrev.00047.2009 · Cited by 2,280
Partitioning of Lipid-Modified Monomeric GFPs into Membrane Microdomains of Live Cells
Zacharias, D. A., Violin, J. D., Newton, A. C., & Tsien, R. Y. (2002) · Science · doi:10.1126/science.1068539 · Cited by 2,235
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195
Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system
Augustin, H. G., Young Koh, G., Thurston, G., & Alitalo, K. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2639 · Cited by 1,465
Self-citationDumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., & Breitman, M. L. (1994) · Genes & Development · doi:10.1101/gad.8.16.1897 · Cited by 985
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
Crossing the endothelial barrier during metastasis
Reymond, N., d'Água, B. B., & Ridley, A. J. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3628 · Cited by 922
Ory, D. S., Neugeboren, B. A., & Mulligan, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11400 · Cited by 912
Cited by
Items 101–200 of 285
Angiopoietin‐Tie signaling in kidney diseases: an updated review
He, F.-F., Zhang, D., Chen, Q., Zhao, Y., Wu, L. L., Li, Z., Zhang, C., Jiang, Z., & Wang, Y. (2019) · FEBS Letters · doi:10.1002/1873-3468.13568 · Cited by 34
Endothelial Progenitor Cells in the Host Defense Response
Shi, X., Seidle, K. A., Simms, K. J., Dong, F., Chilian, W. M., & Zhang, P. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108315 · Cited by 44
Role of Angiopoietin-Tie axis in vascular and lymphatic systems and therapeutic interventions
Wang, R., Yang, M., Jiang, L., & Huang, M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106331 · Cited by 39
Sha, L., Zhao, Y., Li, S., Wei, D., Tao, Y., & Wang, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05441-y · Cited by 42
Amado‐Azevedo, J., van Stalborch, A.-M. D., Valent, E. T., Nawaz, K., van Bezu, J. S. M., Eringa, E. C., Hoevenaars, F. P. M., Cuyper, I. M. D., Hordijk, P. L., van Hinsbergh, V. W. M., et al. (2021) · Angiogenesis · doi:10.1007/s10456-021-09781-x · Cited by 30
The overall process of metastasis: From initiation to a new tumor
Fan, T., Kuang, G., Long, R., Han, Y., & Wang, J. (2022) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2022.188750 · Cited by 36
Kim, J., de Sampaio, P. C., Lundy, D. M., Peng, Q., Evans, K. W., Sugimoto, H., Gagea, M., Kienast, Y., do Amaral, N. S., Rocha, R. M., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90733 · Cited by 35
Stojak, M., Milczarek, M., Kurpińska, A., Suraj, J., Kaczara, P., Wojnar‐Lason, K., Banach, J., Stachowicz-Suhs, M., Rossowska, J., Kalvin's, I. Y., et al. (2020) · Cancers · doi:10.3390/cancers12102850 · Cited by 32
Angiogenesis regulation by nanocarriers bearing RNA interference
Ofek, P., Tiram, G., & Satchi‐Fainaro, R. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.01.008 · Cited by 31
Roles of Integrins in Gastrointestinal Cancer Metastasis
Hou, S., Wang, J., Li, W., Hao, X., & Hang, Q. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.708779 · Cited by 35
Role of angiopoietin-2 in inflammatory autoimmune diseases: A comprehensive review
Wu, Q., Xu, W., & Huang, A. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106223 · Cited by 30
Akwii, R. G., Sajib, M. S., Zahra, F. T., Tullar, P., Zabet‐Moghaddam, M., Zheng, Y., Gutkind, J. S., Doçi, C. L., & Mikelis, C. M. (2022) · Angiogenesis · doi:10.1007/s10456-022-09831-y · Cited by 32
Zhou, X., Pucel, J. C., Nomura-Kitabayashi, A., Chandakkar, P., Bartoletti, A. P., Jhangiani, N. L., Bao, D., Fan, J., Arthur, H. M., Ullmer, C., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319385 · Cited by 27
Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification
Dubin, R. F., Deo, R., Ren, Y., Wang, J., Pico, A. R., Mychaleckyj, J. C., Kozlitina, J., Lamberson, V., Lee, H., Shah, A. M., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae288 · Cited by 33
Immune markers of severe acute pancreatitis
Lee, P. J., Papachristou, G. I., Speake, C., & Lacy‐Hulbert, A. (2024) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000001053 · Cited by 33
Zhang, Y., Han, Y., Zhao, Y., Lv, Y., Hu, Y., Tan, Y., Bi, X., Yu, B., & Kou, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00925 · Cited by 29
Molecular Regulation of Acute Tie2 Suppression in Sepsis
Thamm, K., Schrimpf, C., Retzlaff, J., Idowu, T. O., van Meurs, M., Zijlstra, J. G., Ghosh, C. C., Zeitvogel, J., Werfel, T., Haller, H. G., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003269 · Cited by 27
Conway, G. D., Buzza, M. S., Martin, E. W., et al. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01763-3 · Cited by 28
Butt, O. H., Zhou, A. Y., Ances, B. M., DiPersio, J. F., & Ghobadi, A. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1110647 · Cited by 33
Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency
Loffredo, S., Ferrara, A. L., Bova, M., Borriello, F., Suffritti, C., Veszeli, N., Petraroli, A., Galdiero, M. R., Varricchi, G., Granata, F., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01721 · Cited by 28
Wang, F., Xiao, Y.-J., Neupane, S., Ptak, S. H., Römer, R., Xiong, J., Ohmes, J., Seekamp, A., Fretté, X., Alban, S., et al. (2021) · Marine Drugs · doi:10.3390/md19040194 · Cited by 24
Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
Kiss, E. A., & Saharinen, P. (2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2_4 · Cited by 32
Self-citationProtection and rebuilding of the endothelial glycocalyx in sepsis – Science or fiction?
Drost, C. C., Rovas, A., & Kümpers, P. (2021) · Matrix Biology Plus · doi:10.1016/j.mbplus.2021.100091 · Cited by 29
Aldewereld, Z., Zhang, L. A., Urbano, A., Parker, R. S., Swigon, D., Banerjee, I., Gómez, H., & Clermont, G. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.794423 · Cited by 26
Hultström, M., Fromell, K., Larsson, A. O., Persson, B., Nilsson, B., Quaggin, S. E., Betsholtz, C., Frithiof, R., Lipcsey, M., & Jeansson, M. (2022) · Biomedicines · doi:10.3390/biomedicines10061333 · Cited by 33
Tailor-made molecular imprints for biological event intervention
Ding, F., Ma, Y., Fan, W., Xu, J., & Pan, G. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.02.015 · Cited by 25
Tang, X., Wang, J. J., Wang, J., Abboud, H. E., Chen, Y., & Zhang, S. X. (2020) · Angiogenesis · doi:10.1007/s10456-020-09757-3 · Cited by 26
Yoodee, S., Peerapen, P., Plumworasawat, S., & Thongboonkerd, V. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.02.218 · Cited by 23
Effects of Hypoxia on Cerebral Microvascular Angiogenesis: Benefits or Damages?
Guan, Y., Liu, J., Gu, Y., & Ji, X. (2022) · Aging and Disease · doi:10.14336/ad.2022.0902 · Cited by 47
Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche
Han, H. H., Kim, B. G., Lee, J. H., Kang, S., Kim, J. E., & Cho, N. H. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0086 · Cited by 24
Jia, B., Shi, T., Li, Z., Shan, S., Ji, P., & Li, Z. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.12.120 · Cited by 26
van der Bijl, I., Nawaz, K., Kazlauskaite, U., van Stalborch, A.-M. D., Tol, S., Orgaz, A. J., van den Bout, I., Reinhard, N. R., Sonnenberg, A., & Margadant, C. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.05.005 · Cited by 25
Zhong, Y., Qu, K., Yan, W., et al. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.136198 · Cited by 24
Zou, W., Qian, C., Zhang, S., Wan, X., Wei, Z., Li, X., Wu, Y., Chen, W., Wang, A., Zhao, Y., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7037786 · Cited by 21
Zhou, Y., Yu, Y., Yang, H., Yang, H. K., Huo, Y., Huang, Y. X. R., Tian, X., & Fang, W. (2022) · Cancer Science · doi:10.1111/cas.15375 · Cited by 22
Role of endothelial cells in graft-versus-host disease
Neidemire-Colley, L. M., Robert, J., Ackaoui, A., Dorrance, A. M., Guimond, M., & Ranganathan, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1033490 · Cited by 23
Vascular Morphogenesis: An Integrin and Fibronectin Highway
Hamidi, H., & Ivaska, J. (2017) · Current Biology · doi:10.1016/j.cub.2016.12.036 · Cited by 22
Self-citationEnhancement of nucleus pulposus repair by glycoengineered adipose-derived mesenchymal cells
Ying, L., Liang, C., Zhang, Y., Wang, J., Wang, C., Xia, K., Shi, K., Yu, C., Yang, B., Xu, H., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121463 · Cited by 22
Astrocytes-derived VEGF exacerbates the microvascular damage of late delayed RBI
Zhou, D., Huang, X., Xie, Y., Deng, Z., Guo, J., & Huang, H. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.03.039 · Cited by 21
Deng, Q., Du, F., Pan, S., Xia, Y., Zhu, Y., Zhang, J., Li, C., & Yu, S. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04207-7 · Cited by 27
Cervical cancer cell–derived angiopoietins promote tumor progression
Yang, P., Chen, N., Yang, D., Crane, J. L., Huang, B., Dong, R., Yi, X., Guo, J., Cai, J., & Wang, Z. (2017) · Tumor Biology · doi:10.1177/1010428317711658 · Cited by 20
Zheng, H., Du, W., Duan, Y., Geng, K., Deng, J., & Gao, C. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b14884 · Cited by 22
Improved Immunotherapy Efficacy by Vascular Modulation
Newport, E., Pedrosa, A., Njegić, A., Hodivala‐Dilke, K., & Muñoz‐Félix, J. M. (2021) · Cancers · doi:10.3390/cancers13205207 · Cited by 21
Yu, X., Sha, J., Shao, X., Qin, S., Conrad, P., Ghosh, S. K., Weinberg, A., & Ye, F. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1196303 · Cited by 20
Exosome-loading miR-205: a two-pronged approach to ocular neovascularization therapy
Zhang, H., Zhang, Q., Liu, Q., Feng, S.-G., Ma, Y., Wang, F., Zhu, Y., Yao, J., & Yan, B. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03079-y · Cited by 23
Yao, H., Xu, H., Wu, M., Lei, W., Li, L., Liu, D., Wang, Z., Ran, H., Ma, H., & Zhou, X. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.05.021 · Cited by 19
Sorenson, L., Fu, Y., Hood, T., Warren, S. E., & McEachron, T. A. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1629779 · Cited by 20
Yu, D., Makkar, G., Dong, T., Strickland, D. K., Sarkar, R., & Monahan, T. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141397 · Cited by 19
Salimi, U., Menden, H. L., Mabry, S. M., Xia, S., & Sampath, V. (2021) · Pediatric Research · doi:10.1038/s41390-021-01544-0 · Cited by 18
Todoroki, T., Takeuchi, J., Ota, H., Nakano, Y., Sajiki, A. F., Nakamura, K., Kaneko, H., & Nishiguchi, K. M. (2024) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.65.11.15 · Cited by 18
Kempe, S., Fois, G., Brunner, C., Hoffmann, T. K., Hahn, J., & Greve, J. (2019) · Microcirculation · doi:10.1111/micc.12592 · Cited by 16
Kapiainen, E., Kihlström, M. K., Pietilä, R. S., Kaakinen, M., Ronkainen, V., Tu, H., Heikkinen, A., Devarajan, R., Miinalainen, I., Laitakari, A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1904 · Cited by 18
Self-citationFan, D., Liu, H., Zhang, Z., Su, M., Yuan, Z., Lin, Y., Yang, S., Li, W., & Zhang, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618724 · Cited by 16
Exploring Angiopoietin-2: Clinical Insights and Experimental Perspectives in Kidney Diseases
Luo, A.-J., Chang, F., & Lin, S. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.09.001 · Cited by 17
ICELLNET v2: a versatile method for cell–cell communication analysis from human transcriptomic data
Massenet-Regad, L., & Soumelis, V. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae089 · Cited by 18
Wolfrum, P., Böhm, E. W., Lorenz, K., Stoffelns, B. M., Pfeiffer, N., & Korb, C. A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13154508 · Cited by 17
Saharinen, P., Jeltsch, M., Santoyo, M. M., Leppänen, V., & Alitalo, K. K. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_16 · Cited by 18
Self-citationLee, K., Kim, Y., Yoo, Y. H., Kim, M.-S., Lee, S. H., Kim, C.-G., Park, K.-H., Jeoung, D., Lee, H., Ko, I. Y., et al. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00675-16 · Cited by 17
Huang, R., Andersen, L. M. K., & Rofstad, E. K. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1307-4 · Cited by 18
Wang, T., Li, W., Huang, H., et al. (2019) · Medical Science Monitor · doi:10.12659/msm.912321 · Cited by 15
Tumor Angiogenesis: A Key Target for Cancer Therapy
(2019) · Springer eBooks · doi:10.1007/978-3-319-33673-2 · Cited by 15
Chatterjee, A., Eshwaran, R., Huang, H., Zhao, D., Schmidt, M., Wieland, T., & Feng, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103713 · Cited by 14
VEGI Improves Outcomes in the Early Phase of Experimental Traumatic Brain Injury
Zhou, Z., Gao, S., Li, Y., Peng, R., Zheng, Z., Wei, W., Zhao, Z., Liu, X., Li, L., & Zhang, J. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.042 · Cited by 14
Dichotomous role of integrin‐β5 in lung endothelial cells
Blanchard, N. P., Link, P. A., Farkas, D., Harmon, B. T., Hudson, J., Bogamuwa, S., Piper, B., Authelet, K. J., Cool, C. D., Heise, R. L., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12156 · Cited by 12
Petersen, J. E. V., Mkumbaye, S. I., Vaaben, A. V., et al. (2016) · Scientific Reports · doi:10.1038/srep35950 · Cited by 14
Multiplexed, high-throughput measurements of cell contraction and endothelial barrier function
Rokhzan, R., Ghosh, C. C., Schaible, N., Notbohm, J., Yoshie, H., Ehrlicher, A. J., Higgins, S. J., Zhang, R., Haller, H. G., Hardin, C., et al. (2018) · Laboratory Investigation · doi:10.1038/s41374-018-0136-2 · Cited by 12
Growth factor signaling pathways in vascular development and disease
Grant, Z. L., & Coultas, L. (2019) · Growth Factors · doi:10.1080/08977194.2019.1635591 · Cited by 14
Lim, J. I., Amador, M. J., Dhoot, D. S., Finn, A. P., Fraser‐Bell, S., Gibson, K., Idowu, O. O., Khurana, R. N., Lanzetta, P., Lin, T.-C., et al. (2025) · Ophthalmology Retina · doi:10.1016/j.oret.2025.01.017 · Cited by 20
Angiogenic factors as prognostic markers in neuroendocrine neoplasms
Puliani, G., Sesti, F. F., Anastasi, E., Verrico, M., Tarsitano, M. G., Feola, T., Campolo, F., Gioia, C. R. T. D., Venneri, M. A., Angeloni, A., et al. (2022) · Endocrine · doi:10.1007/s12020-021-02942-4 · Cited by 12
MicroRNA-1 protects the endothelium in acute lung injury
Korde, A., Haslip, M., Pednekar, P., Khan, A., Chioccioli, M., Mehta, S. S., López‐Giráldez, F., Bermejo, S. D., Rojas, M. M., Cruz, C. S. D., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.164816 · Cited by 16
Meder, L., Orschel, C. I., Otto, C. J., Koker, M., Brägelmann, J., Ercanoglu, M. S., Dähling, S., Compes, A., Selenz, C., Nill, M., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.166402 · Cited by 17
Zeng, Z., Gui, C., Li, L., & Wei, X. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.177968 · Cited by 13
Angiopoietin-2 Enhances Osteogenic Differentiation of Bone Marrow Stem Cells
Kang, M., Kim, E., Jeong, S.-Y., & Im, G. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25940 · Cited by 12
Roy-Luzarraga, M., Abdel-Fatah, T. M. A., Reynolds, L. E., Clear, A. J., Taylor, J. G., Gribben, J. G., Chan, S. Y. T., Jones, J. L., & Hodivala‐Dilke, K. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.19304 · Cited by 12
The Angiopoietin—Tie System: Common Signaling Pathways for Angiogenesis, Cancer, and Inflammation
Reiss, Y., Scholz, A., & Plate, K. H. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2907-8_13 · Cited by 18
Plasticity in Materials with Heterogeneous Microstructures
Lyu, H., Ruimi, A., Field, D. P., et al. (2016) · Metallurgical and Materials Transactions A · doi:10.1007/s11661-016-3802-2 · Cited by 13
Age- and BMI-Associated Expression of Angiogenic Factors in White Adipose Tissue of Children
Gäbler, N., Haggenmüller, B., Kapapa, M., Serra, A., Tews, D., Funcke, J., Brandt, S., Ioannidis, V., Schön, M., Möller, P., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205204 · Cited by 14
Li, Y., Peng, S., Xu, J., Liu, W., & Luo, Q. (2025) · PeerJ · doi:10.7717/peerj.19328 · Cited by 16
Antiangiogenic therapy for ocular diseases: Current status and challenges
Chen, R., Zhu, J., Hu, J., & Li, X. (2023) · MedComm – Future Medicine · doi:10.1002/mef2.33 · Cited by 13
Pellowe, A. S., Wu, M. J., Kang, T.-Y., Chung, T. D., Ledesma-Mendoza, A., Herzog, E. L., Levchenko, A., Odell, I. D., Varga, J., & Gonzalez, A. L. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.02.021 · Cited by 13
Reinardy, J. L., Corey, D. M., Golzio, C., Mueller, S. B., Katsanis, N., & Kontos, C. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0139614 · Cited by 12
Truby, L., & Topkara, V. K. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.11.04 · Cited by 12
Circulating angiopoietin-1 and -2 in patients with stable and exacerbated asthma
Lee, P., Kim, B., Seo, H.-J., Park, J., Lee, J., Park, S. W., Kim, D.-J., Park, H., Park, C., & Jang, A. (2016) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2015.12.011 · Cited by 12
Zhang, Y., Zhao, Y., Wu, Y. L., Qi, J., Li, F., Kou, J., & Yu, B. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.34978 · Cited by 13
Chu, C., Chen, X., Hasan, A. A., Szakallova, A., Krämer, B. K., Tepel, M., & Hocher, B. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab332 · Cited by 13
Yadegari, H., Jamil, M. A., Müller, J., Marquardt, N., Rawley, O., Budde, U., El‐Maarri, O., Lillicrap, D., & Oldenburg, J. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005895 · Cited by 13
Impact of Angiopoietin-2 on Kidney Diseases
Li, M., Popovic, Z., Chu, C., Reichetzeder, C., Pommer, W., Krämer, B. K., & Hocher, B. (2023) · Kidney Diseases · doi:10.1159/000529774 · Cited by 11
Chandna, A., Lubell, Y., Mwandigha, L., Tanunchai, P., Vinitsorn, A., Richard‐Greenblatt, M., Koshiaris, C., Limmathurotsakul, D., Nosten, F. H., Abdad, M. Y., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-38731-4 · Cited by 14
Mazzeo, A., Gai, C., Trento, M., Porta, M., & Beltramo, E. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01565-x · Cited by 13
Angiopoietin-2: An Emerging Tie to Pathological Vessel Enlargement
Khosraviani, N., Wu, R., & Fish, J. E. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.121.317102 · Cited by 11
Direct Tie2 Agonists Stabilize Vasculature for the Treatment of Diabetic Macular Edema
Agard, N. J., Zhang, G., Ridgeway, J., DiCara, D. M., Chu, P. Y., Ohri, R. V., Sanowar, S., Vernes, J.-M., Chi, H. M., Zhang, J., et al. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.10.27 · Cited by 11
Hultström, M., Fromell, K., Larsson, A. O., et al. (2021) · medRxiv · doi:10.1101/2021.01.13.21249429 · Cited by 11
New mechanisms and therapeutic approaches to regulate vascular permeability in systemic inflammation
Vu, H. H., Moellmer, S. A., McCarty, O. J. T., & Puy, C. (2025) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000864 · Cited by 11
Loss of the Nuclear Protein RTF2 Enhances Influenza Virus Replication
Chia, B. S., Li, B., Cui, A., Eisenhaure, T., Raychowdhury, R., Lieb, D., & Hacohen, N. (2020) · Journal of Virology · doi:10.1128/jvi.00319-20 · Cited by 11
The utility of inflammatory and endothelial factors in the prognosis of severe dengue
Sivasubramanian, S., Mohandas, S., Gopalan, V., Raj, V. V., Govindan, K., Varadarajan, P., Kaveri, K., & Ramkumar, K. M. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152289 · Cited by 10
Klein, O. R., Ktena, Y. P., Pierce, E. M., Fu, H.-H., Haile, A., Liu, C., & Cooke, K. R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186422 · Cited by 9
Characterization of the Ang/Tie2 Signaling Pathway in the Diaphragm Muscle of DMD Mice
Lin, Y., McClennan, A., & Hoffman, L. (2023) · Biomedicines · doi:10.3390/biomedicines11082265 · Cited by 9
Sidibé, A., Mykuliak, V. V., Zhang, P., Hytönen, V. P., Wu, J., & Wehrle‐Haller, B. (2024) · iScience · doi:10.1016/j.isci.2024.110129 · Cited by 8
Dysregulation of angiopoietin-Tie-2 axis in ugandan children hospitalized with pneumonia
Zhang, R., Rai, U., Ibrahim, N. B. M., Amazouz, Y., Soo, J., Conroy, A. L., Namasopo, S., Opoka, R. O., Bhargava, R., & Hawkes, M. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155175 · Cited by 8
Swamy, H., & Glading, A. (2021) · Journal of Cell Science · doi:10.1242/jcs.258816 · Cited by 9
Metadata
- Authors
- Hakanpaa, L., Sipila, T., Leppanen, V.-M., Gautam, P., Nurmi, H., Jacquemet, G., Eklund, L., Ivaska, J., Alitalo, K., & Saharinen, P.
- Affiliations
- University of Helsinki (FI)
- University of Turku (FI)
- University of Oulu (FI)
- Corresponding author
- Saharinen, Pipsa
- ORCID
- Venue
- Nature Communications
- Published
- 2015-01-30
- Volume
- 6
- Issue
- 1
- Pages
- 5962-5962
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4316742
- OpenAlex
- W2077884715
- Cited by
- 287
- References
- 56
- Citations by year
- 2026: 23 · 2025: 19 · 2024: 31 · 2023: 22 · 2022: 28 · 2021: 27 · 2020: 32 · 2019: 23 · 2018: 23 · 2017: 26 · 2016: 19 · 2015: 12
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Åbo Akademi University Research Portal (submittedVersion)
- Funders
- Fondation Leducq (11CVD03)
- Academy of Finland (20122017, 2014–2019, 271845, 136880)
- FP7 Ideas: European Research Council (268804)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- angiopoietin-2, angiopoietin-1, beta1 integrin, Tie2 receptor, vascular permeability, pathological angiogenesis, stress fibers, cell-matrix adhesion, phosphatidylinositol 3-kinase, Rho kinase
- MeSH terms
- Animals, Cell Line, Female, Humans, Male, Mice, Transgenic, Pregnancy, Integrin beta1, Angiopoietin-1, Angiopoietin-2, Endothelial Cells, Receptor, TIE-2, Mice, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.